Abstract
Technology of generation of induced pluripotent stem cells followed by differentiation into relevant cell type allows obtaining cell models for studying various inherited human diseases. In the study, an induced pluripotent stem cell (iPSC) line (ICGi046-A) was generated as a result of reprogramming of mononuclear cells of a RASopathy patient carrying pathogenic c.775T>A (p.Ser259Thr) variant in RAF1 to the pluripotent state. The ICGi046-A line demonstrated morphology characteristic of human pluripotent cells, normal karyotype (46,XY), expression of pluripotency markers (OCT4, NANOG, SOX2, TRA-1-60), and capacity to give rise to derivatives of three germ layers during spontaneous differentiation. The iPSC line can be used for studying molecular mechanisms of RASopathies.
REFERENCES
Dementyeva, E.V., Pavlova, S.V., Chernyavsky, A.M., and Zakian, S.M., Generation of an induced pluripotent stem cell line, ICGi029-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.N515del mutation in MYBPC3, Stem Cell Res., 2021, vol. 53, p. 102344.
Jaffré, F., Miller, C.L., Schanzer, A., et al., Inducible pluripotent stem cell-derived cardiomyocytes reveal aberrant ERK5 and MEK 1/2 signaling concomitantly promote hypertrophic cardiomyopathy in RAF1-associated Noonan Syndrome, Circulation, 2019, vol. 140, no. 3, pp. 207–224.
Malakhova, A.A., Grigor’eva, E.V., Pavlova, S.V., et al., Generation of induced pluripotent stem cell lines ICGi021-A and ICGi022-A from peripheral blood mononuclear cells of two healthy individuals from Siberian population, Stem Cell Res., 2020, vol. 48, p. 101952.
Melnik, O.V., Gudkova, A.Y., Vershinina, T.L., et al., Clinical polymorphism of RASopathies in terms of the children’s cardiology department, Consilium Medicum, 2017, vol. 19, no. 12, pp. 100–104.
Sorogina, D.A., Grigor’eva, E.V., Malakhova, A.A., et al., Creation of induced pluripotent stem cells ICGi044-B and ICGi044-C using reprogramming of peripheral blood mononuclear cells of a patient with Parkinson’s disease associated with c.1492T>G mutation in the GLUD2 gene, Russ. J. Dev. Biol., 2023, vol. 54, no. 1, pp. 104–111.
ACKNOWLEDGMENTS
The analysis of karyotype was carried out using the resources of the Common Use Center for Microscopy of Biologic Objects, Siberian Branch, Russian Academy of Sciences, supported by the Budget Project of the Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences, FWNR-2022-0015. Equipment of the Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation was used for the analysis of immunofluorescence staining.
Funding
The research was carried out with the financial support of the Russian Science Foundation (project no. 22-15-00271).
Author information
Authors and Affiliations
Contributions
E.V. Dementyeva, A.A. Kostareva, and S.M. Zakian developed the design of the experiment, analyzed the obtained data, and participated in the writing of the article. E.V. Dementyeva and E.S. Klimenko performed reprogramming of mononuclear cells and characterization of the iPSC line. J.M. Minina analyzed the karyotype of the iPSC line.
Corresponding author
Ethics declarations
CONFLICT OF INTEREST
The authors of this work declare that they have no conflicts of interest.
ETHICS APPROVAL AND CONSENT TO PARTICIPATE
The study was approved by the Ethics Committee of the Almazov National Medical Research Center of the Ministry of Health of the Russian Federation, protocol no. 01-22-01C dated January 17, 2022. The patient gave voluntary informed consent.
All applicable international, national, and/or institutional principles for the use of animals in experiments and conditions for their care have been observed for obtaining feeder.
Additional information
Passport of the pluripotent stem cell line
Translated by A. S. Ermakov
Publisher’s Note.
Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dementyeva, E.V., Klimenko, E.S., Minina, J.M. et al. Generation of an Induced Pluripotent Stem Cell Line ICGi046-A of a Patient Carrying Pathogenic p.Ser259Thr Variant in RAF1 Associated with RASopathy. Russ J Dev Biol 54 (Suppl 1), S75–S81 (2023). https://doi.org/10.1134/S1062360423070032
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1062360423070032